Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HyHub™ and HyHub™ Duo Vial Access Devices

K-Number: K243404 · 2025-07-18

Decision Date2025-07-18
Product CodeLHI
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

HyHub™ and HyHub™ Duo Vial Access Devices is a medical device manufactured by Takeda Pharmaceuticals. It received FDA 510(k) clearance on 2025-07-18 under approval number K243404. The device is classified under product code LHI. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HyHub™ and HyHub™ Duo Vial Access Devices?

HyHub™ and HyHub™ Duo Vial Access Devices is a medical device that received FDA 510(k) clearance on 2025-07-18. It is manufactured by Takeda Pharmaceuticals. The 510(k) number is K243404.

When was HyHub™ and HyHub™ Duo Vial Access Devices approved by the FDA?

HyHub™ and HyHub™ Duo Vial Access Devices received FDA 510(k) clearance on 2025-07-18, under approval number K243404.

What company makes HyHub™ and HyHub™ Duo Vial Access Devices?

HyHub™ and HyHub™ Duo Vial Access Devices is manufactured by Takeda Pharmaceuticals.

What is the FDA product code for HyHub™ and HyHub™ Duo Vial Access Devices?

The FDA product code for HyHub™ and HyHub™ Duo Vial Access Devices is LHI.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: LHI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.